Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(e)
As reported by Tilray, Inc. (the “Company”) in its Current Report on Form 8-K dated January 28, 2021, the Company and Andrew Pucher reached the mutual decision to have Mr. Pucher step down as the Company’s Chief Corporate Development Officer, effective as of March 31, 2021 (the “Separation Date”).
On February 8, 2021, the Company entered into a separation agreement and complete release with Mr. Pucher (the “Separation Agreement”) specifying the terms of Mr. Pucher’s separation from service with the Company.
Pursuant to the Separation Agreement, Mr. Pucher will receive payment of Mr. Pucher’s base salary and continued vesting of options and restricted stock units (“RSUs”) through the Separation Date. Mr. Pucher will remain eligible to receive his 2020 annual discretionary bonus in accordance with the Company’s discretional incentive bonus plan. In addition, if the closing date of the proposed arrangement between the Company and Aphria as described on the Company’s Current Report on Form 8-K dated December 21, 2020 (the “Proposed Arrangement”) occurs on or before September 30, 2021, the Company will accelerate the vesting of all unvested RSUs held by Mr. Pucher, such that all RSUs will be fully vested on the closing of the Proposed Arrangement. If the Proposed Arrangement does not close on or before September 30, 2021, any remaining and unvested RSUs held by Mr. Pucher will not vest.
In addition, pursuant to the Separation Agreement, Mr. Pucher is entitled to receive (a) severance payments equal to 20 months of his base salary, (b) contributions by the Company to the health and dental benefit plans in which Mr. Pucher currently participates until November 30, 2022 and (c) a lump sum payment of CAD 250,000.00 (less applicable taxes and withholdings) on the Separation Date (the “Severance Payments”). The Severance Payments are conditional on Mr. Pucher not revoking the Separation Agreement, which includes a general release of claims against the Company or its successor, its subsidiaries and their respective directors, officers and stockholders and other related parties, and allowing such release to become effective.
The foregoing summary of the Separation Agreement is qualified by reference to the Separation Agreement, which is filed herewith as Exhibit 10.1.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
1